Literature DB >> 26244159

Arteriovenous malformation of the vestibulocochlear nerve.

Adam Tucker1, Masao Tsuji1, Yoshitaka Yamada1, Kenichiro Hanabusa1, Tohru Ukita1, Hiroji Miyake1, Takehisa Ohmura1.   

Abstract

We describe a rare case of an arteriovenous malformation (AVM) embedded in the vestibulocochlear nerve presenting with subarachnoid hemorrhage (SAH) treated by microsurgical elimination of the main feeding artery and partial nidus volume reduction with no permanent deficits. This 70-year-old woman was incidentally diagnosed 4 years previously with two small unruptured tandem aneurysms (ANs) on the right anterior inferior cerebral artery feeding a small right cerebellopontine angle AVM. The patient was followed conservatively until she developed sudden headache, nausea and vomiting and presented to our outpatient clinic after several days. Magnetic resonance imaging demonstrated findings suggestive of early subacute SAH in the quadrigeminal cistern. A microsurgical flow reduction technique via clipping between the two ANs and partial electrocoagulation of the nidus buried within the eighth cranial nerve provided radiographical devascularization of the ANs with residual AVM shunt flow and no major deficits during the 2.5 year follow-up. This is only the second report of an auditory nerve AVM. In the event of recurrence, reoperation or application of alternative therapies may be considered.

Entities:  

Keywords:  Arteriovenous malformation; Flow reduction; Microsurgery; Subarachnoid hemorrhage; Vestibulocochlear nerve

Year:  2015        PMID: 26244159      PMCID: PMC4517342          DOI: 10.12998/wjcc.v3.i7.661

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  47 in total

1.  Concerning the mechanism of trigeminal neuralgia and hemifacial spasm.

Authors:  W J GARDNER
Journal:  J Neurosurg       Date:  1962-11       Impact factor: 5.115

2.  Trigeminal neuralgia and arteriovenous aneurysm of the cerebellopontine angle.

Authors:  A B EISENBREY; W M HEGARTY
Journal:  J Neurosurg       Date:  1956-11       Impact factor: 5.115

3.  Glossopharyngeal neuralgia from a posterior fossa arteriovenous malformation: resolution following embolization.

Authors:  S L Galetta; E C Raps; R W Hurst; E S Flamm
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

4.  Surgery for tic douloureux.

Authors:  R I Apfelbaum
Journal:  Clin Neurosurg       Date:  1983

5.  Arteriovenous malformation in the cerebellopontine angle presenting as hemifacial spasm--case report.

Authors:  Y Kim; A Tanaka; M Kimura; S Yoshinaga; M Tomonaga
Journal:  Neurol Med Chir (Tokyo)       Date:  1991-02       Impact factor: 1.742

6.  Microsurgical management of glomus spinal arteriovenous malformations: pial resection technique: Clinical article.

Authors:  Gregory J Velat; Steve W Chang; Adib A Abla; Felipe C Albuquerque; Cameron G McDougall; Robert F Spetzler
Journal:  J Neurosurg Spine       Date:  2012-04-06

7.  Spinal glomus (type II) arteriovenous malformations: a pooled analysis of hemorrhage risk and results of intervention.

Authors:  Bradley A Gross; Rose Du
Journal:  Neurosurgery       Date:  2013-01       Impact factor: 4.654

Review 8.  Challenging traditional beliefs: microsurgery for arteriovenous malformations of the basal ganglia and thalamus.

Authors:  Bradley A Gross; Edward A M Duckworth; Christopher C Getch; Bernard R Bendok; H Hunt Batjer
Journal:  Neurosurgery       Date:  2008-09       Impact factor: 4.654

9.  Bypass and flow reduction for complex basilar and vertebrobasilar junction aneurysms.

Authors:  M Yashar S Kalani; Joseph M Zabramski; Peter Nakaji; Robert F Spetzler
Journal:  Neurosurgery       Date:  2013-05       Impact factor: 4.654

10.  Angioarchitecture determines obliteration rate after radiosurgery in brain arteriovenous malformations.

Authors:  Patamintita Taeshineetanakul; Timo Krings; Sasikhan Geibprasert; Ravi Menezes; Ronit Agid; Karel G Terbrugge; Michael L Schwartz
Journal:  Neurosurgery       Date:  2012-12       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.